Sontag Foundation marks 20 years of funding brain cancer research


In recognition of the 20th anniversary of the Sontag Foundation, its founders Rick and and the late Susan Sontag, have committed an additional $100 million dollars to advance brain cancer research and provide support for brain tumor patients and their caregivers.

This latest funding infusion increases the Sontag family's financial commitment to eradicating brain cancer to more than $200 million.

Since 2002, the Sontags, through the Sontag Foundation’s Distinguished Scientist Award program, have launched the careers of young scientists at academic medical institutions throughout North America. Many of them will be sharing their thoughts and ideas on the advancement of brain cancer research at the Sontag Foundation Retreat, Feb. 6-9 in Ponte Vedra Beach.

This preeminent gathering of more than 100 thought leaders dedicated to eradicating brain cancer is a rare opportunity for collaboration and conversation that has historically been a catalyst to transformative ideas in brain cancer research and care.

In 2022, More than 93,0001 people were diagnosed with primary brain tumors. Through the Brain Tumor Network, a first of its kind, free individualized navigation service, developed by the Sontag Foundation through the support of the Sontag family, patients and loved ones have access to a service to help manage their brain tumor diagnosis, overcome treatment obstacles and facilitate access to quality health care across their entire journey.

The Sontags also believe in supporting local and have provided more than $10 million in support to nonprofit organizations in Northeast Florida and established a brain tumor support group, which meets monthly to support locally families impacted by a brain tumor diagnosis.


No comments on this item Please log in to comment by clicking here